A RetroSearch Logo

Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Search Query:

Showing content from https://pubmed.ncbi.nlm.nih.gov/26465985/ below:

A Trial of Calcium and Vitamin D for the Prevention of Colorectal Adenomas

Randomized Controlled Trial

. 2015 Oct 15;373(16):1519-30. doi: 10.1056/NEJMoa1500409. A Trial of Calcium and Vitamin D for the Prevention of Colorectal Adenomas Elizabeth L BarryLeila A MottJudy R ReesRobert S SandlerDale C SnoverRoberd M BostickAnastasia IvanovaBernard F ColeDennis J AhnenGerald J BeckRobert S BresalierCarol A BurkeTimothy R ChurchMarcia Cruz-CorreaJane C FigueiredoMichael GoodmanAdam S KimDouglas J RobertsonRichard RothsteinAasma ShaukatMarch E SeabrookRobert W Summers

Affiliations

Affiliation

Item in Clipboard

Randomized Controlled Trial

A Trial of Calcium and Vitamin D for the Prevention of Colorectal Adenomas

John A Baron et al. N Engl J Med. 2015.

. 2015 Oct 15;373(16):1519-30. doi: 10.1056/NEJMoa1500409. Authors John A Baron  1 Elizabeth L BarryLeila A MottJudy R ReesRobert S SandlerDale C SnoverRoberd M BostickAnastasia IvanovaBernard F ColeDennis J AhnenGerald J BeckRobert S BresalierCarol A BurkeTimothy R ChurchMarcia Cruz-CorreaJane C FigueiredoMichael GoodmanAdam S KimDouglas J RobertsonRichard RothsteinAasma ShaukatMarch E SeabrookRobert W Summers Affiliation

Item in Clipboard

Abstract

Background: Epidemiologic and preclinical data suggest that higher intake and serum levels of vitamin D and higher intake of calcium reduce the risk of colorectal neoplasia. To further study the chemopreventive potential of these nutrients, we conducted a randomized, double-blind, placebo-controlled trial of supplementation with vitamin D, calcium, or both for the prevention of colorectal adenomas.

Methods: We recruited patients with recently diagnosed adenomas and no known colorectal polyps remaining after complete colonoscopy. We randomly assigned 2259 participants to receive daily vitamin D3 (1000 IU), calcium as carbonate (1200 mg), both, or neither in a partial 2×2 factorial design. Women could elect to receive calcium plus random assignment to vitamin D or placebo. Follow-up colonoscopy was anticipated to be performed 3 or 5 years after the baseline examinations, according to the endoscopist's recommendation. The primary end point was adenomas diagnosed in the interval from randomization through the anticipated surveillance colonoscopy.

Results: Participants who were randomly assigned to receive vitamin D had a mean net increase in serum 25-hydroxyvitamin D levels of 7.83 ng per milliliter, relative to participants given placebo. Overall, 43% of participants had one or more adenomas diagnosed during follow-up. The adjusted risk ratios for recurrent adenomas were 0.99 (95% confidence interval [CI], 0.89 to 1.09) with vitamin D versus no vitamin D, 0.95 (95% CI, 0.85 to 1.06) with calcium versus no calcium, and 0.93 (95% CI, 0.80 to 1.08) with both agents versus neither agent. The findings for advanced adenomas were similar. There were few serious adverse events.

Conclusions: Daily supplementation with vitamin D3 (1000 IU), calcium (1200 mg), or both after removal of colorectal adenomas did not significantly reduce the risk of recurrent colorectal adenomas over a period of 3 to 5 years. (Funded by the National Cancer Institute; ClinicalTrials.gov number, NCT00153816.).

PubMed Disclaimer

Figures

Figure 1. Subgroup Analysis of the Effects…

Figure 1. Subgroup Analysis of the Effects of Supplementation with Calcium or Vitamin D on…

Figure 1. Subgroup Analysis of the Effects of Supplementation with Calcium or Vitamin D on the Development of One or More Adenomas

The body-mass index (BMI) is the weight in kilograms divided by the square of the height in meters. NSAID denotes nonsteroidal anti-inflammatory drug.

Similar articles Cited by References
    1. Brown AJ, Dusso A, Slatopolsky E. Vitamin D. Am J Physiol. 1999;277:F157–F175. - PubMed
    1. Leyssens C, Verlinden L, Verstuyf A. Antineoplastic effects of 1,25(OH)2D3 and its analogs in breast, prostate and colorectal cancer. Endocr Relat Cancer. 2013;20:R31–R47. - PubMed
    1. Feldman D, Krishnan AV, Swami S, Giovannucci E, Feldman BJ. The role of vitamin D in reducing cancer risk and progression. Nat Rev Cancer. 2014;14:342–357. - PubMed
    1. Harris DM, Go VL. Vitamin D and colon carcinogenesis. J Nutr. 2004;134(Suppl):3463S–3471S. - PubMed
    1. Touvier M, Chan DS, Lau R, et al. Meta-analyses of vitamin D intake, 25-hydroxyvitamin D status, vitamin D receptor polymorphisms, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 2011;20:1003–1016. - PubMed

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3